Fundz

Advancell Closes A$18M Series B Funding Led By Morningside

PRIVATEAug 24, 2022

Round Type

Series B

SydneyBiotechnologyHealth CareTherapeutics

Description

AdvanCell, an Australian radiopharmaceutical company with a platform technology for a revolutionary cancer treatment called Targeted Alpha Therapy, announced today the closing of an A$18 million Series B financing round led by Morningside.

Quick answer

AdvanCell raised an undisclosed amount in a Series B round, dated August 24, 2022. AdvanCell is based in Sydney, New South Wales, Australia.

How much did AdvanCell raise?
AdvanCell raised an undisclosed amount in a Series B round on August 24, 2022.
What does AdvanCell do?
AdvanCell is a vertically integrated, clinical-stage radiopharmaceutical company dedicated to developing innovative cancer therapies that harness the power of targeted alpha-emitting radionuclides.
Where is AdvanCell based and how big is it?
AdvanCell is based in Sydney, New South Wales, Australia. Fundz records about 96 employees.
Who are the decision-makers at AdvanCell?
Fundz holds 1 contact at AdvanCell, including the Managing Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as AdvanCell that raised within 45 days of this round, from Fundz verified event records.

  • RadioMedix raised $40M (Series A) on October 7, 2022.
  • NewcelX raised $4M (Seed) on October 7, 2022.
  • Valitor raised an undisclosed amount (Series B) on October 5, 2022.
  • Vergent Bioscience raised $22M (Series B) on October 4, 2022.
  • Cellarity raised $121M (Series C) on October 4, 2022.
  • Gamida Cell raised $25M (Funding Round) on September 28, 2022.

Who to call at AdvanCell, and when

A new round usually means AdvanCell is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day AdvanCell raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at AdvanCell, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at AdvanCell. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

AdvanCell

Location

Macquarie Street

Sydney, New South Wales, Australia

About

AdvanCell is a vertically integrated, clinical-stage radiopharmaceutical company dedicated to developing innovative cancer therapies that harness the power of targeted alpha-emitting radionuclides. By leveraging its proprietary Lead-212 platform, advanced and scalable manufacturing capabilities and world-class clinical development capabilities, AdvanCell aims to deliver novel treatments that improve outcomes for patients with cancer globally.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment AdvanCell raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsAndrew A., Managing DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for AdvanCell's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

AdvanCell raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.